TRDA short interest
Entrada Therapeutics Inc. · Healthcare · Biotechnology · settlement date 2026-09-30
| Shares short | 2,989,455 |
|---|---|
| Change vs prior report | 245,310 (+8.9%) |
| Change over six months | +234.3% |
| Days to cover | 9.86 (sector: 3.78) |
| Average daily volume | 303,169 |
| Rank in Healthcare | #115 of 922 by days to cover |
TRDA short interest, last 12 months
| Settlement | Shares short | Change | Days to cover | Avg daily volume |
|---|---|---|---|---|
| 2026-09-30 | 2,989,455 | +8.9% | 9.86 | 303,169 |
| 2026-09-15 | 2,744,145 | +17.0% | 8.06 | 340,415 |
| 2026-08-31 | 2,345,803 | -0.9% | 10.69 | 219,451 |
| 2026-08-14 | 2,367,019 | +10.4% | 6.15 | 384,854 |
| 2026-07-31 | 2,143,736 | -3.9% | 4.33 | 494,747 |
| 2026-07-15 | 2,230,697 | +5.6% | 6.26 | 356,582 |
| 2026-06-30 | 2,111,685 | +10.4% | 5.85 | 360,809 |
| 2026-06-15 | 1,913,294 | +10.8% | 8.00 | 239,128 |
| 2026-05-29 | 1,727,002 | +14.5% | 4.47 | 386,626 |
| 2026-05-15 | 1,507,737 | +51.0% | 1.55 | 972,065 |
| 2026-04-30 | 998,352 | +17.1% | 5.48 | 182,150 |
| 2026-04-15 | 852,247 | -4.7% | 5.53 | 154,155 |
| 2026-03-31 | 894,152 | -3.3% | 4.70 | 190,100 |
| 2026-03-13 | 924,265 | +12.3% | 3.50 | 264,152 |
| 2026-02-27 | 822,864 | -9.5% | 4.81 | 171,223 |
| 2026-02-13 | 908,901 | +1.4% | 4.65 | 195,458 |
| 2026-01-30 | 896,142 | +4.4% | 3.13 | 286,600 |
| 2026-01-15 | 858,462 | +12.9% | 3.93 | 218,611 |
| 2025-12-31 | 760,344 | -15.4% | 4.37 | 174,083 |
| 2025-12-15 | 898,798 | -5.2% | 4.87 | 184,643 |
| 2025-11-28 | 948,628 | +2.4% | 3.75 | 253,092 |
| 2025-11-14 | 926,483 | +3.7% | 2.66 | 348,857 |
| 2025-10-31 | 893,790 | -5.3% | 4.78 | 187,084 |
| 2025-10-15 | 944,223 | +16.1% | 5.49 | 171,990 |
| 2025-09-30 | 813,393 | -22.9% | 1.65 | 491,778 |
import finzdata as yf
yf.Ticker("TRDA").short_interest # every report since 2017
yf.Client().short_interest(["TRDA"], start="2018-01-01")Healthcare short interest · TRDA price history · Who owns TRDA · All short interest